Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „shows“
Suchtreffer
Begriffe & Kennungen
Dabigatran Etexilate Accord · 4.8 · Table 18 shows the adverse reactions identified from the studies in the treatment of VTE and prevention of rec
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · The table 11 shows the number (%) of patients experiencing the adverse reaction bleeding during the treatment
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · The table 13 shows the number (%) of patients experiencing the adverse reaction bleeding during the treatment
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · The table 14 shows bleeding events broken down to major and any bleeding in the pivotal study testing the prev
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · Treatment of DVT and PE, and prevention of recurrent DVT and PE in adults (DVT/PE treatmen t) Table 13 shows b
Eintrag öffnenDapagliflozin Viatris · 4.8 · 9 a The table shows up to 24-week (short-term) data regardless of glycaemic rescue. b See corresponding subsec
Eintrag öffnenDelstrigo · 4.5 · Table 1 shows the established and other potential medicinal product interactions with the individual component
Eintrag öffnenDocetaxel Accord · 4.8 · Neutropenic complications Table below shows that the incidence of Grade 4 neutropenia, febrile neutropenia and
Eintrag öffnenDocetaxel Kabi · 4.8 · Neutropenic complications Table below shows that the incidence of Grade 4 neutropenia, febrile neutropenia and
Eintrag öffnenDocetaxel Kabi · 4.8 · Neutropenic complications Table below shows that the incidence of Grade 4 neutropenia, febrile neutropenia and
Eintrag öffnenDocetaxel Kabi · 4.8 · Neutropenic complications Table below shows that the incidence of Grade 4 neutropenia, febrile neutropenia and
Eintrag öffnenDocetaxel Kabi · 4.8 · Neutropenic complications Table below shows that the incidence of Grade 4 neutropenia, febrile neutropenia and
Eintrag öffnenDocetaxel Kabi · 4.8 · Neutropenic complications Table below shows that the incidence of Grade 4 neutropenia, febrile neutropenia and
Eintrag öffnenEbilfumin · 4.8 · Table 2 shows the most frequently reported ARs from paediatric clinical trials. Table 2 Adverse reactions in s
Eintrag öffnenEliquis · 4.8 · Table 2 shows the adverse reactions ranked under headings of system organ class and frequency using the follow
Eintrag öffnenEliquis · 4.8 · Table 2 shows the adverse reactions ranked under headings of system organ class and frequency using the follow
Eintrag öffnenEliquis · 4.8 · Table 3 shows the adverse reactions ranked under headings of system organ class and frequency using the follow
Eintrag öffnenEliquis · 4.8 · Table 3 shows the adverse reactions ranked under headings of system organ class and frequency using the follow
Eintrag öffnenErvebo · 4.8 · Individuals 1 year of age and older Table 1 shows the adverse reactions observed in recipients of Ervebo.
Eintrag öffnenEsbriet · 4.8 · Table 1 shows the adverse reactions reported at a frequency of ≥2% in 623 patients receiving Esbriet at the re
Eintrag öffnen